Binghai X. Zhou

Nanchang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

An evaluation of the effectiveness of 3D virtual imaging combined with intraoperative ultrasonography to guide liver staining in anatomic segmental hepatectomy.

An evaluation of the effectiveness of 3D virtual imaging combined with intraoperative ultrasonography to guide liver staining in anatomic segmental hepatectomy.

Journal: Global health & medicine
Published: April 27, 2025

SIRPα blockade therapy potentiates immunotherapy by inhibiting PD-L1+ myeloid cells in hepatocellular carcinoma.

SIRPα blockade therapy potentiates immunotherapy by inhibiting PD-L1+ myeloid cells in hepatocellular carcinoma.

Journal: Cell death & disease
Published: March 03, 2025

PARG inhibition halts cholangiocarcinoma progression via the Hippo pathway and enhances response to chemotherapy and immunotherapy.

PARG inhibition halts cholangiocarcinoma progression via the Hippo pathway and enhances response to chemotherapy and immunotherapy.

Journal: Journal of hepatology
Published: February 05, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb.

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb.

Journal: Journal of visualized experiments : JoVE
Published: February 03, 2025

SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion.

SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion.

Journal: Oncoimmunology
Published: July 11, 2024

Association between dementia, Alzheimer's disease, and liver cancer: A Mendelian randomization analysis.

Association between dementia, Alzheimer's disease, and liver cancer: A Mendelian randomization analysis.

Journal: Journal of Alzheimer's disease reports
Published: May 31, 2024

SLC7A11 in hepatocellular carcinoma: potential mechanisms, regulation, and clinical significance.

SLC7A11 in hepatocellular carcinoma: potential mechanisms, regulation, and clinical significance.

Journal: American journal of cancer research
Published: March 06, 2024

The deubiquitinating enzyme USP44 suppresses hepatocellular carcinoma progression by inhibiting Hedgehog signaling and PDL1 expression.

The deubiquitinating enzyme USP44 suppresses hepatocellular carcinoma progression by inhibiting Hedgehog signaling and PDL1 expression.

Journal: Cell death & disease
Published: July 27, 2023

CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma.

CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma.

Journal: Journal of hepatology
Published: June 19, 2023

Exosomes with IR780 and Lenvatinib loaded on GPC3 single-chain scFv antibodies for targeted hyperthermia and chemotherapy in hepatocellular carcinoma therapy.

Exosomes with IR780 and Lenvatinib loaded on GPC3 single-chain scFv antibodies for targeted hyperthermia and chemotherapy in hepatocellular carcinoma therapy.

Journal: American journal of cancer research
Published: June 10, 2023

Disulfiram combined with chemoimmunotherapy potentiates pancreatic cancer treatment efficacy through the activation of cGAS-STING signaling pathway via suppressing PARP1 expression.

Disulfiram combined with chemoimmunotherapy potentiates pancreatic cancer treatment efficacy through the activation of cGAS-STING signaling pathway via suppressing PARP1 expression.

Journal: American journal of cancer research
Published: October 04, 2022

Complement C5 is a novel biomarker for liver metastasis of colorectal cancer.

Complement C5 is a novel biomarker for liver metastasis of colorectal cancer.

Journal: Journal of gastrointestinal oncology
Published: July 25, 2022
Showing 1-12 of 27

Last Updated: 09/26/2026